{"symbol":"BSX","fiscalQuarter":"Q4-2023","reportDate":"2024-01-31","reportTime":"BMO","status":"reported","company":{"name":"Boston Scientific Corporation","sector":"Health Care","industry":"Health Care Equipment"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/BSX/earnings/Q4-2023","postBrief":{"headline":"Boston Scientific Misses on EPS, Stock Up 3.0%","keyNumbers":[{"metric":"EPS","actual":"$0.34","expected":"N/A","surprise":"-33.46%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["Management highlighted ongoing investments in innovation and market expansion.","They acknowledged the challenges faced in the quarter but remain focused on long-term growth.","The team expressed confidence in their strategic initiatives despite the EPS miss."],"summary":"Management conveyed a cautious optimism about future growth opportunities. They emphasized their commitment to innovation and market expansion."},"guidanceChanges":{"summary":"No guidance updates were provided during the earnings call.","changes":[]},"whatItMeans":"The earnings report indicates that Boston Scientific faced challenges this quarter, particularly reflected in their EPS miss. However, the stock rose by 3% likely due to positive sentiment around their long-term strategies and investments in innovation. Investors may be encouraged by management's focus on growth despite the short-term setback.","metaDescription":"Boston Scientific (BSX) Q4 2023 earnings: EPS missed expectations. Stock up 3.0%. Full breakdown."}}